Recombinant Enterococcus faecalis Citrate lyase acyl carrier protein (citD)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Enterococcus faecalis Citrate Lyase Acyl Carrier Protein (citD)

Recombinant Enterococcus faecalis Citrate lyase acyl carrier protein, denoted as citD, is a crucial component of the citrate lyase complex in Enterococcus faecalis. This protein plays a pivotal role in the citrate fermentation pathway, which is essential for the bacterium's survival and pathogenicity in various environments. The citrate lyase complex splits citrate into oxaloacetate and acetate, facilitating anaerobic fermentation processes.

Structure and Function of citD

The citD protein is part of the citrate lyase complex, which includes three subunits: citD (acyl carrier protein), citE (citryl-ACP oxaloacetate lyase), and citF (acetyl-ACP:citrate ACP-transferase) . citD acts as a carrier protein, facilitating the transfer of acyl groups during the enzymatic reactions involved in citrate metabolism.

Protein DetailsDescription
Protein NameCitrate lyase acyl carrier protein (citD)
Alternative NameCitrate lyase gamma chain
SourceEnterococcus faecalis (strain ATCC 700802 / V583)
Expression Region1-102 amino acids
Purity>85% (SDS-PAGE)
Uniprot No.Q82YW1

Research Findings and Implications

Research on citD and the citrate fermentation pathway in Enterococcus faecalis highlights its importance in the bacterium's ability to thrive in diverse environments. The citrate fermentation pathway is crucial for the bacterium's pathogenicity, as it enhances growth in environments such as blood and urine . The presence of the complete citrate pathway in all E. faecalis strains underscores its role in metabolic preservation and persistence across different habitats .

References

  1. Transcriptional Regulation of the Citrate Gene Cluster of Enterococcus faecalis. PMC2576652.

  2. The Enterococcus faecalis FabT Transcription Factor Regulates Fatty Acid Synthesis. Frontiers in Microbiology.

  3. Transcriptional Regulation of the Citrate Gene Cluster of Enterococcus faecalis. Journal of Bacteriology.

  4. Implications of the expression of Enterococcus faecalis citrate fermentation pathway. PubMed.

  5. Recombinant Enterococcus faecalis Citrate lyase acyl carrier protein (citD). Cusabio.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference for your application.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its implementation.
Synonyms
citD; EF_3321Citrate lyase acyl carrier protein; Citrate lyase gamma chain
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-102
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Enterococcus faecalis (strain ATCC 700802 / V583)
Target Names
citD
Target Protein Sequence
MKIIKNATAG TVESSDIMIT VQPIESTENT IELESSVEKQ FGNQIRQVIT TTLEHLDVQG VAVKAIDKGA LDCTIKARMI TVLHRGAEKE TYDWKELDSW NV
Uniprot No.

Target Background

Function
Covalent carrier of the coenzyme of citrate lyase.
Database Links

KEGG: efa:EF3321

STRING: 226185.EF3321

Protein Families
CitD family
Subcellular Location
Cytoplasm.

Q&A

What is the functional role of citrate lyase acyl carrier protein (citD) in the citrate metabolism pathway?

The citrate lyase acyl carrier protein (citD) is a critical subunit of the citrate lyase complex in Enterococcus faecalis. This complex is essential for the initial step of citrate fermentation, where it catalyzes the splitting of citrate into oxaloacetate and acetate. The citD protein functions specifically as the acyl carrier component within this multienzyme complex, which is encoded as part of the oadHDB-citCDEFX-oadA-citMG operon . As an acyl carrier protein, citD likely requires post-translational modification to attach a prosthetic group necessary for its catalytic function in the citrate lyase complex.

How is the expression of citD regulated in E. faecalis?

The expression of citD is governed by a sophisticated transcriptional regulation system centered around the GntR transcriptional regulator CitO. The citD gene is part of the oadHDB-citCDEFX-oadA-citMG operon, which is specifically activated in the presence of citrate in the growth medium . Transcriptional analysis has revealed that CitO acts as a novel positive regulator that binds to cis-acting sequences O₁ and O₂ in the intergenic region between the divergent citHO and oadHDB-citCDEFX-oadA-citMG operons .

Research approaches to study this regulation include:

  • Constructing reporter gene fusions to monitor promoter activity

  • Performing electrophoretic mobility shift assays (EMSAs) to verify CitO binding to the regulatory regions

  • Creating citO knockout strains to confirm the regulatory relationship

  • Quantitative RT-PCR to measure transcript levels in response to different conditions

The affinity of CitO for its binding sites increases significantly when citrate is present, allowing for the coordinated induction of both cit promoters .

What are the optimal conditions for expressing recombinant citD in heterologous systems?

Successful expression of recombinant citD requires careful optimization of several parameters:

ParameterRecommended ConditionsRationale
Expression HostE. coli BL21(DE3) or similarLacks lon and ompT proteases; compatible with T7 expression system
Growth Temperature16-25°CReduces inclusion body formation for better solubility
Induction0.1-0.5 mM IPTGLower concentrations favor proper folding
Media Supplements5-10% glycerolStabilizes protein during expression
Lysis BufferpH 7.5-8.0 with 10% glycerolMaintains stability during purification

When expressing citD, researchers should be aware that as an acyl carrier protein, it likely requires post-translational phosphopantetheinylation to be fully functional. This modification may need to be engineered into heterologous expression systems by co-expressing the appropriate phosphopantetheinyl transferase.

A methodological approach would include testing multiple strains, optimizing codon usage for the expression host, and validating protein activity through functional assays involving the complete citrate lyase complex .

What barriers exist in genetic manipulation of E. faecalis for citD studies, and how can they be overcome?

Working with Enterococcus faecalis presents significant challenges for genetic manipulation that directly impact citD studies:

  • Physical barriers: E. faecalis possesses a thick cell wall that limits DNA uptake during transformation procedures .

  • Enzymatic barriers: Multiple restriction modification (RM) systems, including types I, II, and IV, as well as CRISPR-Cas systems, impede the introduction of foreign DNA .

  • Strain variability: Laboratory strains amenable to transformation (such as JH2-2) are not representative of clinical isolates, limiting translational relevance .

To overcome these barriers, researchers can employ several strategies:

  • Use DNA isolated from the same E. faecalis strain to avoid restriction

  • Methylate plasmid DNA prior to transformation to protect against restriction enzymes

  • Optimize electroporation conditions with higher voltage and shorter pulse duration

  • Employ temperature-sensitive vectors for genomic integration (such as pGh9 used for citO interruption)

  • Consider conjugation-based methods for DNA transfer

  • Utilize the JH2-2 strain for initial studies, as it has been successfully used for genetic manipulations in citrate metabolism research

For targeted modification of citD, a single recombination approach similar to that used for citO interruption could be applied, where an internal fragment of citD is cloned into a thermosensitive vector like pGh9 .

What role does citD play in E. faecalis virulence and adaptation to different environments?

While direct evidence linking citD to virulence is limited in the search results, citrate metabolism likely contributes to E. faecalis adaptation to various ecological niches:

  • Gastrointestinal tract: Citrate utilization may provide a competitive advantage in the nutrient-limited environment of the human and animal microflora, where E. faecalis is a natural member .

  • Food environments: Citrate fermentation plays an important role in aroma development during cheese production and other fermented foods, contributing to E. faecalis' beneficial role in food production .

  • Potential connection to virulence: As a nosocomial pathogen, E. faecalis must adapt to different nutrient conditions during infection. The ability to utilize citrate could potentially contribute to persistence in certain infection sites.

Research methodologies to explore this connection might include:

  • Comparing citD expression levels between commensal and clinical isolates

  • Creating citD knockout strains and testing virulence in infection models

  • Evaluating growth in citrate-containing media that mimics specific host environments

  • Transcriptomic analysis comparing citD expression under various stress conditions

Understanding the role of citD in adaptation may help explain E. faecalis' ability to transition between commensal and pathogenic lifestyles.

What are the critical controls needed when studying recombinant citD function in vitro?

When investigating recombinant citD function, researchers should implement the following critical controls:

Control TypePurposeImplementation
Negative enzymatic controlVerify specificity of activityHeat-inactivated citD protein
Post-translational modification controlEnsure proper protein activationComparison of modified vs. unmodified citD
Substrate specificity controlConfirm catalytic specificityTest alternative substrates structurally similar to citrate
Complex formation controlVerify proper assemblySize-exclusion chromatography or native PAGE
Activity reconstitutionConfirm functional complementationMixing purified citD, citE, and citF subunits

Additionally, researchers should verify protein identity through mass spectrometry and confirm the presence of expected post-translational modifications. When reconstituting the complete citrate lyase complex, stoichiometric ratios of citD, citE, and citF should be optimized and verified .

How can researchers differentiate between the roles of citD and other components of the citrate fermentation pathway?

Differentiating the specific contributions of citD from other components in the citrate fermentation pathway requires several methodological approaches:

  • Gene-specific knockouts: Creating individual knockout strains for citD, citE, citF, and other pathway components allows researchers to identify phenotypic differences specific to each gene's function .

  • Complementation studies: Reintroducing functional copies of each gene (as demonstrated with citO) can confirm gene-specific effects and rule out polar effects on downstream genes .

  • Biochemical reconstitution: In vitro reconstitution of the citrate lyase complex with purified components, systematically omitting or replacing individual subunits, can reveal their specific contributions.

  • Protein-protein interaction studies: Techniques such as bacterial two-hybrid assays, co-immunoprecipitation, or surface plasmon resonance can map the interaction network within the complex.

  • Structural biology approaches: Solving the structure of individual components and the assembled complex can provide mechanistic insights into how each subunit contributes to catalysis.

The citrate fermentation pathway in E. faecalis involves multiple proteins across two operons, making it essential to isolate the specific role of citD through these complementary approaches .

How might citD be utilized as a target for antimicrobial development against E. faecalis infections?

CitD presents a potential target for antimicrobial development based on several characteristics:

  • Metabolic importance: As part of the citrate lyase complex, citD is involved in a key metabolic pathway that may be essential for E. faecalis survival in certain environments or infection sites .

  • Unique structure: As an acyl carrier protein with specific post-translational modifications, citD likely contains structural features distinct from host proteins, potentially allowing for selective targeting.

  • Conserved function: The citrate lyase complex is involved in all known anaerobic bacterial citrate fermentation pathways, suggesting potential broad-spectrum applications .

Research approaches for antimicrobial development could include:

  • High-throughput screening of compound libraries for inhibitors of citD function

  • Structure-based drug design targeting the active site or protein-protein interaction surfaces

  • Peptidomimetic inhibitors that disrupt complex assembly

  • Prodrugs activated by the citrate metabolism pathway

Given the increasing prevalence of antibiotic resistance in enterococci, novel targets like citD could provide alternative therapeutic strategies focusing on virulence attenuation rather than growth inhibition.

What is the relationship between citD function and other metabolic pathways in E. faecalis under various environmental conditions?

The interconnection between citD-mediated citrate metabolism and other metabolic pathways in E. faecalis represents an important area for future research:

  • Carbon flux distribution: How does citrate utilization affect central carbon metabolism under different growth conditions? Methodological approaches would include metabolic flux analysis using isotope-labeled substrates.

  • Regulatory cross-talk: Investigation of how the CitO regulator interacts with other transcriptional networks could reveal integration points between citrate metabolism and other pathways .

  • Environmental adaptation: Studies examining citD expression and activity across different oxygen levels, pH values, and nutrient compositions would illuminate its role in environmental adaptation.

  • Metabolic engineering applications: Understanding citD's role in the broader metabolic network could inform strategies for engineering E. faecalis strains with enhanced properties for food or industrial applications.

The citrate metabolism pathway in E. faecalis produces acetate, CO₂, formate, and smaller quantities of lactate, acetoin, and ethanol, suggesting connections to multiple metabolic pathways that could be explored through systems biology approaches .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.